|

Parkinson's Disease Clinical Trials in New York, NY

27 recruiting studies within 50 miles

Phase
Trial Phase Dist.
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor ComplicationsPhase 3<1 mi
Parkinson's Foundation PD GENEration Genetic Registry—<1 mi
A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's DiseasePhase 1/2<1 mi
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's DiseasePhase 2<1 mi
Exploring the Effects of Spinal Cord Stimulation in Parkinson's Disease.N/A<1 mi
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's DiseasePhase 3<1 mi
Novel Shoe Device NUSHU to Measure Gait Analysis in Parkinson's PatientsN/A<1 mi
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease—<1 mi
Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL)Phase 1/2<1 mi
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications—<1 mi
Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)Phase 2<1 mi
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort—<1 mi
Autoimmune Features of Neurodegenerative Disorders—<1 mi
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseasePhase 3<1 mi
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's DiseasePhase 2/3<1 mi
Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's DiseaseEarly 1<1 mi
Drug Discovery for Parkinson's With Mutations in the GBA Gene—<1 mi
Parkinson's Disease Biomarkers in Nerve Cells in the Gut—<1 mi
A Study of Buntanetap in Participants With PDPhase 2/3<1 mi
Rehabilitation of Airway Protection in Parkinson's DiseasePhase 2<1 mi
NYSCF Scientific Discovery Biobank—<1 mi
Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease—16 mi
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry—16 mi
Effects Of Osteopathic Manipulative Medicine(OMM) On Lower Extremity Muscle Characteristics In Parkinson's Disease(PD) PatientsN/A22 mi
A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's DiseasePhase 238 mi
Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:—38 mi
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's DiseasePhase 438 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.